2026
Ionetix Corporation (“Ionetix” or the “Company”), a manufacturer of proprietary superconducting cyclotrons and producer of medical isotopes for diagnostic imaging and targeted alpha therapy, today announced it has begun
Ionetix Corporation (“Ionetix” or the “Company”), a manufacturer of proprietary superconducting cyclotrons and producer of medical isotopes for diagnostic imaging and targeted alpha therapy, today announced
Deep Fission, Inc. (Nasdaq: FISN) (“Deep Fission” or the “Company”), an advanced nuclear energy company developing small modular pressurized water reactors installed one mile underground, today announced that the
FedEx Corp. (NYSE: FDX) and Dexterity Inc., the enterprise physical AI company building intelligent robots for complex
Matternet, the world's only FAA Type-Certified drone delivery platform, today announced the appointment of Sanjay Shah to its Board of Directors
Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, today announced that it has signed a letter of intent (LOI)
Deep Isolation Nuclear, Inc. (OTCQB: DBHL) (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today welcomed the U.S.
Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that it has entered into a securities purchase agreement
Deep Isolation Nuclear, Inc. (OTCQB: DBHL) (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today announced that it has been selected
Company’s participation follows Nasdaq listing and announcement of customer pipeline representing up to 18.5 GW of potential generation capacity
Deep Fission, Inc. (“Deep Fission” or the “Company”), an advanced nuclear energy company developing small modular pressurized water reactors installed one mile underground
Ionetix Corporation (“Ionetix”), a leading particle accelerator company focused on the medical, materials testing and nuclear energy space,
Department of Commerce Announces Letters of Intent With Nine Companies for More Than $2 Billion to Accelerate U.S. Leadership in Quantum Computing
Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies
Deep Isolation Nuclear, Inc. (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today announced
Deep Isolation Nuclear, Inc. (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today
Deep Fission, Inc. (“Deep Fission” or the “Company”), an advanced nuclear energy company developing small modular
Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable
Deep Fission, Inc. (“Deep Fission” or the “Company”) and Accelerant Solutions today announced the signing of a multi-
Deep Fission, Inc. (“Deep Fission” or the “Company”), a pioneering advanced nuclear energy company
r4 Technologies, a cross enterprise artificial intelligence (AI) software firm, is about
Eridan, a U.S.-based developer of fully digital radio technology, today announced the successful integration of its AI-native radio
Deep Fission, Inc. (“Deep Fission” or the “Company”), a pioneering advanced nuclear energy company placing small modular pressurized water reactors
Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies
Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein replacement therapies, today announced that its Board of Directors
r4 Federal today announced the appointment of Vice Admiral Trey Whitworth, USN (Ret.), as President of National Security, effective
Deep Isolation Nuclear, Inc. (“Deep Isolation”), a leading innovator in nuclear waste disposal technology, today
Deep Isolation Nuclear, Inc. (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today announced the successful
r4 Federal, the defense-focused operating unit of r4 Technologies, announced it has been selected as an awardee
2025
r4 Federal, the defense-focused operating unit of r4 Technologies, announced it has been selected as an awardee
Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide
Deep Isolation Nuclear, Inc. (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today announced the completion
Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies
Deep Isolation Nuclear, Inc. (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, announced that
Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies
Deep Isolation Nuclear, Inc. (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today
Deep Isolation Nuclear, Inc. (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today
Deep Fission, Inc., a pioneering advanced nuclear energy company placing 15 MWe small modular reactors (SMRs) in boreholes one
Deep Isolation Nuclear, Inc. (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today confirmed
Deep Isolation Nuclear, Inc. (together with its subsidiaries “Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal
Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or “the Company”), a transformative semiconductor company specializing
Deep Fission, Inc. (“Deep Fission” or the “Company”), a pioneering advanced nuclear energy company placing small modular pressurized water reactors in
Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and protein replacement therapies,
Deep Fission, Inc. (“Deep Fission” or the “Company”), a pioneering advanced nuclear energy company placing small modular pressurized water reactors in
Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement
Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies
Patero, a leader in post-quantum cryptography, and Eridan, a pioneer in Open Radio Access Network (Open RAN) technology, today announced the
Deep Isolation Nuclear, Inc., a leading innovator in nuclear waste disposal technology, announced that on
Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies
Saab, Inc. has selected Anduril Rocket Motor Systems as a supplier to design, develop, qualify, and eventually produce
Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies,
Anduril and Meta are partnering to design, build, and field a range of integrated XR products that provide warfighters
Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies, together with Thorlabs
Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies
Aeluma, Inc. (OTCQB:ALMU) ("Aeluma" or "the Company"), a semiconductor company specializing in
OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, entered into a
Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance, scalable technologies for mobile, automotive, AI, defense and
2024
Eridan, a startup developing the world’s smallest, lightest, and most efficient 5G radio, today announced it has been awarded $36.8 million in
Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance, scalable technologies
Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance, scalable technologies for
Aeluma, Inc., (OTCQB:ALMU), a semiconductor company specializing in high-performance, scalable technologies
Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided
Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance, scalable technologies for
Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided
Serve Robotics, Inc.. ("Serve") (Nasdaq: SERV), a leading autonomous delivery robotics company, today announced
Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced
Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for
Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for
2023
Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides
Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for
Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides
Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for
Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for
Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for
Entera Bio Ltd. (NASDAQ: ENTX, “Entera”) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (NASDAQ: OPK,
Guerrilla RF, Inc. (OTCQX: GUER), a leading provider of state-of-the-art radio frequency and microwave
Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical
Serve Robotics, Inc. (“the Company” or “Serve”), the leading autonomous sidewalk delivery company, today a
Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective sensor technologies
Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer
Ostendo Technologies, Inc., and Veea Inc. today announced the signing of a letter of intent to combine Ostendo’s
Guerrilla RF, Inc. (OTCQX: GUER), a leading provider of state-of-the-art RF and microwave communications
Aeluma, Inc. (the "Company") (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective
2022
Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered peptides and therapeutic proteins, announced today the execution of the following key milestones:
Aeluma, Inc., announced today that it has named Thomas Laux as Vice President of Business Development.
2021
Virsec Systems, Inc. secures $100 million “show of force” investment as it redefines how software is secured.
Angion Biomedica Corp. (NASDAQ: ANGN) announces closing of 117 million initial public offering and concurrent private placement
2020
9 Meters Biopharma, Inc. (NASDAQ: NMTR) announces agreement with the European Biomedical Research Institute of Salerno (EBRIS) to continue evaluation of larazotide for COVID-19 respiratory complications
Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) announces FDA approval of IND application for EB613 – an oral human parathyroid hormone (1-34) for the treatment of osteoporosis
Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) announces completion of enrollment in phase 2 clinical trial of Eb613 In osteoporosis
2019
Peernova, an enterprise blockchain software startup that helps banks and financial institutions simplify reconciliation and other data processes, has raised $31 million in new funding.
Angion Biomedica Corp. (NASDAQ: ANGN) announces several strategic additions to its management team to support the future development and commercialization of ANG-3777
Angion Biomedica Corp. (NASDAQ: ANGN) presents late-breaking data on ANG-377 in delayed graft function at the American Society of Nephrology Kidney Week 2019.
Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) to merge with RDD Pharma creating new gastroenterology company focused on specialty, rare and orphan diseases.
Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) reports positive results from a phase 2 PK/PD study of Oral PTH (1-34) in patients with hypoparathyroidism.
Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) announced that three abstracts were accepted for presentations during the 2019 Digestive Disease Week (DDW) conference.
Neurotrope, Inc. (NASDAQ: NTRP) announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the research and clinical development of Bryostatin-1.
Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) announced today the positive outcome of a pre-IND meeting held with the US Food and Drug Administration (FDA) to disscuss the Company’s development plan for Oral PTH for the treatment of osteoporosis.
Angion Biomedica Corp. (NASDAQ: ANGN), a late-stage clinical biopharmaceutical company focused on kidney diseases and other acute organ injuries, announces the recent closing of a $35 million equity private placement.
2018
Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) announced today that it has entered into a research collaboration and license agreement with Amgen in inflammatory disease and other serious illnesses.
Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) announced today that Patrick H. Griffin, M.D., F.A.C.P. has joined as the acting head of clinical development.
Angion Biomedica Corp. (NASDAQ: ANGN) and Sinovant Sciences today announced a collaboration and license agreement for BB3, which is shown to have improved renal function post-transplant.
Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) announced today that it has received positive results from the first part of its pharmacokinetic (PK) and pharmacodynamic (PD) study in patients with hypoparathyroidism treated with its oral parathyroid hormone (PTH) drug.
Innovate Biopharmaceuticals, Inc. (“Innovate”) (NASDAQ: INNT) announces it intends to present at the Jefferies 2018 London Healthcare Conference. The conference is being held on November 14-15, 2018.
HZO Inc. announced today that it has acquired Semblant Ltd., a U.K.-based leader in protective nano coatings and waterproof technology.
Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) announced today the appointment of Faith L. Charles and Miranda J. Toledano to the company’s board of directors, effective immediately.
Innovate Biopharmaceuticals, Inc. (“Innovate”) (NASDAQ: INNT), announced it intends to present at the Ladenburg Thalmann 2018 Healthcare Conference. The conference is being held on October 2, 2018, at the Sofitel Hotel in New York City.
Neurotrope, Inc. (NASDAQ: NTRP), announces that Dr. Charles Ryan, Neurotrope's Chief Executive Officer, will present a company overview at the Ladenburg Thalmann 2018 Healthcare Conference in New York on Tuesday, October 2nd, 2018.
Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) today announced the appointment of Arthur C. Santora II, MD, PhD as its new Chief Medical Officer, effective immediately.
Neurotrope Inc. (NASDAQ: NTRP) is announcing a collaboration with The Nemours / Alfred I. duPont Hospital for Children ("Nemours") to initiate a clinical trial in children with Fragile X Syndrome ("Fragile X").
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) announced today that it has dosed the first patient in the Company’s Phase 1 combination clinical trial of its lead proprietary immuno-oncology drug.
Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) today announced its second quarter 2018 financial results and provided an operating update.
Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) reported its second quarter 2018 financial results and key highlights.
ViewRay, Inc. (NASDAQ: VRAY) today announced the pricing of an underwritten public offering of 16,216,217 shares of common stock.
Neurotrope, Inc. (NASDAQ: NTRP) today provided a business update outlining recent clinical development progress and other noteworthy events that occurred subsequent to the end of the quarter and unaudited financial results for the quarter ended June 30, 2018.
Entera Bio Ltd. (NASDAQ: ENTX and ENTXW), announced today the appointment of Mr. Gerald Lieberman as the chairman of the board of directors, effective as of August 6, 2018.
READ MORE
Solbright Group, Inc. (OTC: SBRT) and M2M Spectrum Networks, LLC today announce the signing of a merger agreement creating the first publicly-traded, pure-play, fully-featured IoT network operating company in the U.S., Iota Communications, Inc. (“Iota”).
Innovate Biopharmaceuticals Inc. (NASDAQ: INNT) announced today that it has been added as a member of the broad-market Russell 3000®, 2000® and Microcap® Indexes as part of the 2018 Russell indexes reconstitution.
Innovate Biopharmaceuticals, Inc. (“Innovate”) (NASDAQ: INNT) today announced the appointment of Saira Ramasastry, to its Board of Directors (Board).
Innovate Biopharmaceuticals, Inc. (“Innovate”) (NASDAQ: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory disease, intends to present on larazotide for celiac disease at BIO 2018 in Boston on Tuesday, June 5th.
Neurotrope, Inc. (NASDAQ: NTRP) announces completion of the study design for its confirmatory Phase 2 clinical trial in moderate to severe Alzheimer’s disease.
CALIENT Technologies, Inc., the global leader for optical switching technology, today announced the Edge|640™, a new Optical Circuit Switch (OCS) with 640 fiber-optic cross connections – up to twice the capacity of the company’s market leading S320 OCS.
Search
Press Release Archives
Archive
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 9 Meters
- Aeluma
- Anduril
- Augmedix
- Deep Fission
- Deep Isolation
- Dexterity
- Eridan
- Guerilla
- HzO
- Ionetix
- Lumicell
- Ostendo
- Serve Robotics
- aeluma
- anduril
- angion
- calient technologies
- entera bio
- eridan
- guerrilla
- healthmine
- innovate biopharmaceuticals
- ionetix
- iota communications
- matternet
- neurotrope
- peernova
- pieris
- r4
- smartkem
- viewray
- virsec